Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Appointed director
Inv. presentation
Appointed CFO
|
|
PDL BIOPHARMA, INC. (PDLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/07/2020 |
4/A
| Imbrogno Edward (VP Finance, CAO and Acting CFO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 292,208 shares
@ $0 |
|
| 04/07/2020 |
4/A
| Monnet Dominique (President and CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 1,233,766 shares
@ $0 |
|
| 04/07/2020 |
4/A
| Jene Jill M. (VP, Business Development) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 194,805 shares
@ $0 |
|
| 04/07/2020 |
4/A
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 422,078 shares
@ $0 |
|
| 04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/16/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/28/2016 |
4/A
| Stone Christopher Lewis (VP, Gen. Counsel & Secretary) has filed a Form 4 on PDL BIOPHARMA, INC. |
| 04/17/2009 |
4/A
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC. |
| 04/13/2009 |
4/A
| SANDMAN PAUL W (Director) has filed a Form 4 on PDL BIOPHARMA, INC. |
|
|